TickerFacts.

CapsoVision, Inc (CV): Capital Expenditures

Annual figures by period end, from SEC filings.

$90.0K
Year ended 2025-12-31
$68.0K
Trailing 12 months to 2026-06-30
$153.0K2024-12-31: $153.0K2025-12-31: $90.0K$90.0K
2024-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$90.0K-41.2%2026-03-26, From 2025-01-01
2024-12-31$153.0Kn/a2026-03-26, From 2024-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
CapsoVision, Inc (CV)2025-12-31$90.0K-41.2%
Hyperfine, Inc. (HYPR)2025-12-31$1.19M+209.4%
Escalon Medical Corp (ESMC)2025-06-30$3.9K-90.4%
QT Imaging Holdings, Inc. (QTI)2025-12-31$124.0K+40.9%
Precision Optics Corporation, Inc. (POCI)2025-06-30$227.2K-16.6%
Nuwellis, Inc. (NUWE)2025-12-31$90.0K+50.0%
electroCore, Inc. (ECOR)2025-12-31$66.0Kn/a
Stereotaxis, Inc. (STXS)2025-12-31$93.0K+173.5%
Neuraxis, Inc (NRXS)2025-12-31$31.1K+12.1%

Compare CV, HYPR, ESMC, QTI side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗